...
首页> 外文期刊>Cancer Cell >Non-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis
【24h】

Non-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis

机译:对SIRT3的非癌基因成瘾在淋巴瘤中起着关键作用

获取原文
获取原文并翻译 | 示例
           

摘要

Diffuse large B cell lymphomas (DLBCLs) are genetically heterogeneous and highly proliferative neoplasms derived from germinal center (GC) B cells. Here, we show that DLBCLs are dependent on mitochondrial lysine deacetylase SIRT3 for proliferation, survival, self-renewal, and tumor growth in vivo regardless of disease subtype and genetics. SIRT3 knockout attenuated B cell lymphomagenesis in VavP-Bcl2 mice without affecting normal GC formation. Mechanistically, SIRT3 depletion impaired glutamine flux to the TCA cycle via glutamate dehydrogenase and reduction in acetyl-CoA pools, which in turn induce autophagy and cell death. We developed a mitochondrial-targeted class I sirtuin inhibitor, YC8-02, which phenocopied the effects of SIRT3 depletion and killed DLBCL cells. SIRT3 is thus a metabolic non-oncogene addiction and therapeutic target for DLBCLs.
机译:弥漫性大B细胞淋巴瘤(DLBCLS)是衍生自发射生发中心(GC)B细胞的基因异质和高增殖的肿瘤。 在这里,我们表明DLBCLS依赖于线粒体赖氨酸脱乙酰酶SIRT3以进行体内的增殖,存活,自我更新和肿瘤生长,无论疾病亚型和遗传学如何。 SIRT3敲除衰减B细胞淋巴瘤在VAVP-BCL2小鼠中而不影响正常的GC形成。 机械地,SIRT3耗尽通过谷氨酸脱氢酶和减少乙酰-CoA池中的谷氨酰胺通量减少到TCA周期,这反过来诱导自噬和细胞死亡。 我们开发了一种线粒体靶向I类Sirtuin抑制剂,YC8-02,其衰弱SIRT3耗竭和杀死DLBCL细胞的影响。 因此,SIRT3是DLBCLS的代谢非癌基因成瘾和治疗靶标。

著录项

  • 来源
    《Cancer Cell》 |2019年第6期|共25页
  • 作者单位

    Weill Cornell Med Dept Med Div Hematol &

    Med Oncol New York NY 10065 USA;

    Cornell Univ Dept Chem &

    Chem Biol Ithaca NY 14853 USA;

    Univ Michigan Dept Mol &

    Integrat Physiol Med Sch Ann Arbor MI 48109 USA;

    Weill Cornell Med Dept Med Div Hematol &

    Med Oncol New York NY 10065 USA;

    Cornell Univ Dept Chem &

    Chem Biol Ithaca NY 14853 USA;

    Weill Cornell Med Dept Med Div Hematol &

    Med Oncol New York NY 10065 USA;

    Weill Cornell Med Dept Med Div Hematol &

    Med Oncol New York NY 10065 USA;

    Cornell Univ Dept Chem &

    Chem Biol Ithaca NY 14853 USA;

    Cornell Univ Dept Chem &

    Chem Biol Ithaca NY 14853 USA;

    Weill Cornell Med Div Biostat &

    Epidemiol New York NY 10021 USA;

    Univ Texas MD Anderson Canc Ctr Dept Lymphoma Myeloma Houston TX 77005 USA;

    Weill Cornell Med Dept Med Div Hematol &

    Med Oncol New York NY 10065 USA;

    Weill Cornell Med Dept Med Div Hematol &

    Med Oncol New York NY 10065 USA;

    Weill Cornell Med Dept Med Div Hematol &

    Med Oncol New York NY 10065 USA;

    Mem Sloan Kettering Canc Ctr Canc Biol &

    Genet Program New York NY 10065 USA;

    Weill Cornell Med Meyer Canc Ctr New York NY 10065 USA;

    Univ Texas MD Anderson Canc Ctr Dept Lymphoma Myeloma Houston TX 77005 USA;

    Cornell Univ Dept Chem &

    Chem Biol Ithaca NY 14853 USA;

    Weill Cornell Med Dept Med Div Hematol &

    Med Oncol New York NY 10065 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号